The aggregation of amyloid β peptides (Aβ) into amyloid fibrils is implicated in the pathology of Alzheimer's disease. In light of the increasing number of proteins reported to retard Aβ fibril formation, we investigated the influence of small hydrophilic model proteins of different charge on Aβ aggregation kinetics and their interaction with Aβ. We followed the amyloid fibril formation of Aβ40 and Aβ42 using thioflavin T fluorescence in the presence of six charge variants of calbindin D 9k and singlechain monellin. The formation of fibrils was verified with transmission electron microscopy. We observe retardation of the aggregation process from proteins with net charge +8, +2, −2, and −4, whereas no effect is observed for proteins with net charge of −6 and −8. The single-chain monellin mutant with the highest net charge, scMN+8, has the largest retarding effect on the amyloid fibril formation process, which is noticeably delayed at as low as a 0.01:1 scMN+8 to Aβ40 molar ratio. scMN+8 is also the mutant with the fastest association to Aβ40 as detected by surface plasmon resonance, although all retarding variants of calbindin D 9k and single-chain monellin bind to Aβ40.
The
fibril formation of the neurodegenerative peptide amyloid β
(Aβ42) is sensitive to solution conditions, and several proteins
and peptides have been found to retard the process. Aβ42 fibril
formation was followed with ThT fluorescence in the presence of polyamino
acids (poly-glutamic acid, poly-lysine, and poly-threonine) and other
polymers (poly(acrylic acid), poly(ethylenimine), and poly(diallyldimethylammonium
chloride). An accelerating effect on the Aβ42 aggregation process
is observed from all positively charged polymers, while no effect
is seen from the negative or neutral polymers. The accelerating effect
is dependent on the concentration of positive polymer in a highly
reproducible manner. Acceleration is observed from a 1:500 polymer
to Aβ42 weight ratio and up. Polyamino acids and the other polymers
exert quantitatively the same effect at the same concentrations based
on weight. Fibrils are formed in all cases as verified by transmission
electron microscopy. The concentrations of polymers required for acceleration
are too low to affect the Aβ42 aggregation process through increased
ionic strength or molecular crowding effects. Instead, the acceleration
seems to arise from the locally increased Aβ42 concentration
near the polymers, which favors association and affects the electrostatic
environment of the peptide.
The enzymatic activity of human carbonic anhydrase II (HCAII) was studied in the presence of nanoparticles of different nature and charge. Negatively charged nanoparticles inhibit HCAII whereas no effect is seen for positively charged particles. The kinetic effects were correlated with the strength of binding of the enzyme to the particle surface as measured by ITC and adsorption assays. Moreover, conformational changes upon adsorption were observed by circular dichroism. The main initial driving force for the adsorption of HCAII to nanoparticles is of electrostatic nature whereas the hydrophobic effect is not strong enough to drive the initial binding. This is corroborated by the fact that HCAII do not adsorb on positively charged hydrophobic polystyrene nanoparticles. Furthermore, the dehydration of the particle and protein surface seems to play an important role in the inactivation of HCAII by carboxyl-modified polystyrene nanoparticles. On the other hand, the inactivation by unmodified polystyrene nanoparticles is mainly driven by intramolecular interactions established between the protein and the nanoparticle surface upon conformational changes in the protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.